142 related articles for article (PubMed ID: 21395654)
1. Relative bioavailability of terbutaline to the lung following inhalation, using urinary excretion.
Abdelrahim ME; Assi KH; Chrystyn H
Br J Clin Pharmacol; 2011 Apr; 71(4):608-10. PubMed ID: 21395654
[TBL] [Abstract][Full Text] [Related]
2. Relative bioavailability of sodium cromoglycate to the lung following inhalation, using urinary excretion.
Aswania OA; Corlett SA; Chrystyn H
Br J Clin Pharmacol; 1999 Jun; 47(6):613-8. PubMed ID: 10383538
[TBL] [Abstract][Full Text] [Related]
3. A method for determination of the absolute pulmonary bioavailability of inhaled drugs: terbutaline.
Borgström L; Nilsson M
Pharm Res; 1990 Oct; 7(10):1068-70. PubMed ID: 2281038
[TBL] [Abstract][Full Text] [Related]
4. Urinary pharmacokinetic methodology to determine the relative lung bioavailability of inhaled beclometasone dipropionate.
Said AS; Harding LP; Chrystyn H
Br J Clin Pharmacol; 2012 Sep; 74(3):456-64. PubMed ID: 22299644
[TBL] [Abstract][Full Text] [Related]
5. Relative bioavailability of salbutamol to the lung following inhalation when administration is prolonged.
Silkstone VL; Tomlinson HS; Corlett SA; Chrystyn H
Br J Clin Pharmacol; 2000 Sep; 50(3):281-4. PubMed ID: 10971315
[TBL] [Abstract][Full Text] [Related]
6. Determination of the relative bioavailability of salbutamol to the lungs and systemic circulation following nebulization.
Silkstone VL; Corlett SA; Chrystyn H
Br J Clin Pharmacol; 2002 Aug; 54(2):115-9. PubMed ID: 12207629
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary deposition of inhaled terbutaline: comparison of scanning gamma camera and urinary excretion methods.
Borgström L; Newman S; Weisz A; Morén F
J Pharm Sci; 1992 Aug; 81(8):753-5. PubMed ID: 1403719
[TBL] [Abstract][Full Text] [Related]
8. Terbutaline: level the playing field for inhaled β
Jacobson GA; Hostrup M
Br J Sports Med; 2017 Sep; 51(18):1323-1324. PubMed ID: 27461883
[TBL] [Abstract][Full Text] [Related]
9. Comparative pharmacokinetics of salbutamol inhaled from a pressurized metered dose inhaler either alone or connected to a newly enhanced spacer design.
Ammari WG; Oriquat GA; Sanders M
Eur J Pharm Sci; 2020 Apr; 147():105304. PubMed ID: 32165316
[TBL] [Abstract][Full Text] [Related]
10. Relative bioavailability of salbutamol to the lung following inhalation using metered dose inhalation methods and spacer devices.
Hindle M; Chrystyn H
Thorax; 1994 Jun; 49(6):549-53. PubMed ID: 8016791
[TBL] [Abstract][Full Text] [Related]
11. Assessment of different methods of inhalation from salbutamol metered dose inhalers by urinary drug excretion and methacholine challenge.
Tomlinson HS; Corlett SA; Allen MB; Chrystyn H
Br J Clin Pharmacol; 2005 Dec; 60(6):605-10. PubMed ID: 16305584
[TBL] [Abstract][Full Text] [Related]
12. Relative lung and total systemic bioavailability following inhalation from a metered dose inhaler compared with a metered dose inhaler attached to a large volume plastic spacer and a jet nebuliser.
Silkstone VL; Corlett SA; Chrystyn H
Eur J Clin Pharmacol; 2002 Jan; 57(11):781-6. PubMed ID: 11868799
[TBL] [Abstract][Full Text] [Related]
13. Emitted dose and lung deposition of inhaled terbutaline from Turbuhaler at different conditions.
Abdelrahim ME
Respir Med; 2010 May; 104(5):682-9. PubMed ID: 20004090
[TBL] [Abstract][Full Text] [Related]
14. An evaluation of the systemic bioavailability of mometasone furoate (MF) after oral inhalation from a MF/formoterol fumarate metered-dose inhaler versus an MF dry-powder inhaler in healthy subjects.
Kosoglou T; Hubbell J; Kantesaria B; Hanson ME; Cutler DL
Clin Pharmacol Drug Dev; 2014 May; 3(3):229-34. PubMed ID: 27128613
[TBL] [Abstract][Full Text] [Related]
15. Comparison of gamma scintigraphy and a pharmacokinetic technique for assessing pulmonary deposition of terbutaline sulphate delivered by pressurized metered dose inhaler.
Newman S; Steed K; Hooper G; Källén A; Borgström L
Pharm Res; 1995 Feb; 12(2):231-6. PubMed ID: 7784338
[TBL] [Abstract][Full Text] [Related]
16. Investigating pulmonary and systemic pharmacokinetics of inhaled olodaterol in healthy volunteers using a population pharmacokinetic approach.
Borghardt JM; Weber B; Staab A; Kunz C; Formella S; Kloft C
Br J Clin Pharmacol; 2016 Mar; 81(3):538-52. PubMed ID: 26348533
[TBL] [Abstract][Full Text] [Related]
17. Real-life effectiveness of inhaler device switch from dry powder inhalers to pressurized metred-dose inhalers in patients with asthma treated with ICS/LABA.
Park HS; Yoon D; Lee HY; Ban GY; Wan Yau Ming S; Jie JLZ; Carter V; Hardjojo A; Van Boven JFM; Price DB
Respirology; 2019 Oct; 24(10):972-979. PubMed ID: 31038269
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of terbutaline in chronic kidney disease.
Bastiansen A; Eggert S; Pedersen E
Eur J Clin Pharmacol; 2013 Nov; 69(11):1951-4. PubMed ID: 23900693
[TBL] [Abstract][Full Text] [Related]
19. Dose-response relationship and reproducibility of urinary salbutamol excretion during the first 30 min after an inhalation.
Tomlinson HS; Corlett SA; Chrystyn H
Br J Clin Pharmacol; 2003 Aug; 56(2):225-7. PubMed ID: 12895197
[TBL] [Abstract][Full Text] [Related]
20. Addition of intravenous beta(2)-agonists to inhaled beta(2)-agonists for acute asthma.
Travers AH; Milan SJ; Jones AP; Camargo CA; Rowe BH
Cochrane Database Syst Rev; 2012 Dec; 12():CD010179. PubMed ID: 23235685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
